9633 — Tokyo Theatres Co Balance Sheet
0.000.00%
- ¥10bn
- ¥12bn
- ¥18bn
- 43
- 60
- 75
- 66
Annual balance sheet for Tokyo Theatres Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4,675 | 3,729 | 2,343 | 2,401 | 3,624 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,078 | 471 | 752 | 540 | 522 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,900 | 7,456 | 7,117 | 7,331 | 8,880 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14,413 | 13,890 | 13,666 | 13,534 | 16,018 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 26,108 | 23,927 | 23,582 | 24,564 | 28,908 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,766 | 3,956 | 4,154 | 4,483 | 4,096 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 14,835 | 11,911 | 11,637 | 11,872 | 13,380 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 11,272 | 12,016 | 11,945 | 12,692 | 15,528 |
| Total Liabilities & Shareholders' Equity | 26,108 | 23,927 | 23,582 | 24,564 | 28,908 |
| Total Common Shares Outstanding |